logo
EDO Launches Engaged Audience Planning, Empowering Brands, Agencies, Networks, and Streamers to Elevate Advanced Audiences and Outcomes-Based Planning for 2025 Upfronts Decisions

EDO Launches Engaged Audience Planning, Empowering Brands, Agencies, Networks, and Streamers to Elevate Advanced Audiences and Outcomes-Based Planning for 2025 Upfronts Decisions

Yahoo24-04-2025

EDO announces interoperability with major audience planning tools, including Nielsen, VideoAmp, Kantar Media, and AI programmatic optimization solutions like DoubleVerify Scibids AI™
NEW YORK, April 24, 2025--(BUSINESS WIRE)--EDO, the TV outcomes company, is launching Engaged Audience Planning to help convergent TV marketers optimize media plans for both reach and outcomes within their existing planning solutions. The interoperable offering delivers an automated, scalable way for advertisers to test various investment scenarios and fine-tune their strategies before committing to a final media plan — making it especially valuable for buyers and sellers navigating the uncertainty of cross-platform Upfront negotiations.
Powered by vertical AI, EDO uses syndicated data to analyze ad-driven consumer engagement behaviors — such as brand searches and website visits — across all linear and streaming TV, measuring more than 110 trillion cross-platform impressions since 2015. According to one recent case study, a leading TV advertiser that combined these predictive outcomes with audience optimization generated over a 3x greater lift in ad-driven engagement as compared to a traditional, audience-only media plan. Engaged Audience Planning delivers a streamlined process, offering clearer insights with less manual work.
EDO's offering is compatible with every major audience planning tool, including those like Nielsen, VideoAmp, and Kantar Media, as well as algorithm-driven programmatic optimization solutions such as DoubleVerify Scibids AI™. The solution also allows more seamless compatibility within clients' existing workflows, including leading media agency planning approaches.
"Marketers consistently tell us they want their Convergent TV investments to deliver on both brand and demand goals — and Engaged Audience Planning is designed to do just that," said Kevin Krim, CEO, EDO. "By aligning EDO's outcome measurement with whatever advanced audience marketers choose, we're empowering advertisers to optimize for both reach and results within their existing planning workflows. Now, clients can confidently set audience targets, define their desired spend, and assess trade-offs to build more engaging reach at a fair CPM or max bid — maximizing ROI from their convergent TV strategies."
"In integrating EDO's new capabilities into our Omni-enabled planning process, we can now incorporate consumer intent, enabling better efficiency and effectiveness for our clients," said Megan Pagiluca, Chief Product Officer, Omnicom Media Group.
"As advertisers turn to CTV to improve both brand impact and performance, we're seeing rapid growth in programmatic CTV investment as a strategic way to reach and engage audiences," said Mark Zagorski, CEO, DoubleVerify. "By integrating with EDO's Engaged Audience Planning, DV Scibids AI empowers brands to intelligently optimize their programmatic CTV campaigns—driving stronger engagement and measurable outcomes that matter."
"Kantar Media views data interoperability as essential to a healthy advertising ecosystem and our TechEdge Audience Analytics software has always supported that as a core value proposition," said Nicole Gileadi, Chief Strategy Officer; MD, North America, Kantar Media. "We're excited to see EDO embrace this same approach with outcome measurement that is compatible with established tools and workflows."
Engaged Audience Planning represents another key milestone in EDO's commitment to industry interoperability. Following the introduction of Engaged Impressions with Nielsen last year, EDO continues to evolve how buyers and sellers optimize for both impact and efficiency in Convergent TV advertising.
For more information on EDO's Engaged Audience Planning, please visit edo.com/Upfronts.
About EDO
EDO is the TV outcomes company. Our leading measurement platform connects convergent TV airings to the ad-driven consumer behaviors most predictive of future sales. EDO empowers the advertising industry to maximize media impact, optimize creative performance, and know the fair value of every impression — across linear and streaming for an increasingly programmatic world. By combining immediate engagement signals with world-class decision science and vertical AI, EDO equips industry leaders with syndicated, investment-grade data that aligns media to business results — with detailed competitive, category, and historical insights. Leading brands, agencies, networks, streamers, and studios trust EDO's TV intelligence to know what works.
About DoubleVerify
DoubleVerify ("DV") (NYSE: DV) is the industry's leading media effectiveness platform that leverages AI to drive superior outcomes for global brands. By powering media efficiency and performance, DV strengthens the online advertising ecosystem, preserving the fair value exchange between buyers and sellers of digital media.
Learn more at www.doubleverify.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250423337180/en/
Contacts
Media contact KCSA for EDOedo@kcsa.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nucor Corporation (NUE): A Bull Case Theory
Nucor Corporation (NUE): A Bull Case Theory

Yahoo

time11 hours ago

  • Yahoo

Nucor Corporation (NUE): A Bull Case Theory

We came across a bullish thesis on Nucor Corporation (NUE) on Business Model Mastery's Substack. In this article, we will summarize the bulls' thesis on NUE. Nucor Corporation (NUE)'s share was trading at $108.94 as of 29th May. NUE's trailing and forward P/E were 19.20 and 14.14 respectively according to Yahoo Finance. A steel rod, bent and contoured to the exact specifications of the company. Nucor stands out as a vertically integrated steel producer operating through three synergistic segments—steel mills, steel products, and raw materials—underpinned by its control of critical inputs, including 3.5 million metric tons of direct reduced iron (DRI) and 18 million tons of recycled scrap annually. This integration enables tight cost control and reliable supply chains. The company's strategic focus on high-value products like insulated panels, overhead doors, and custom racking systems has driven meaningful margin expansion, further bolstered by premium-branded offerings such as ECONIQ™ and AEOS™, which meet growing demand in low-carbon and seismic-resistant construction markets. Nucor's operational flexibility is a core strength, with nearly all production relying on electric arc furnaces (EAFs) that offer rapid scalability and deliver 60–70% lower carbon emissions compared to traditional blast furnaces. Its micro mill strategy and regional footprint enhance both cost efficiency and environmental performance. The company's unique decentralized culture, with just 200 employees at headquarters overseeing over 32,000 teammates, empowers plant-level decision-making and incentivizes performance, driving innovation and responsiveness. This structure supports its aggressive capex-driven growth strategy—$11.8 billion deployed over the past three years, with 63% allocated to capacity expansion and 37% to acquisitions. These investments target fast-growing sectors such as data centers, renewable energy, and automated warehousing, positioning Nucor for long-term structural advantage. The company's integrated model, flexible operations, and disciplined capital deployment collectively support a compelling narrative of margin growth, sustainable production leadership, and strategic evolution in key demand verticals. For a comprehensive analysis of another standout stock covered by the same author, we recommend reading our summary of their of Sanofi (SNY). Since our coverage, the stock is up 4.7%. Nucor Corporation (NUE) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 51 hedge fund portfolios held NUE at the end of the first quarter which was 50 in the previous quarter. While we acknowledge the potential of NUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nanalysis Announces Fully Subscribed $2 Million Note Offering
Nanalysis Announces Fully Subscribed $2 Million Note Offering

Yahoo

time11 hours ago

  • Yahoo

Nanalysis Announces Fully Subscribed $2 Million Note Offering

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ CALGARY, AB, June 6, 2025 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that its previously disclosed offering of 12% unsecured promissory notes (the "Notes") for aggregate gross proceeds of $2,000,000 (the "Offering") is now fully subscribed. As part of the Offering, the Company will issue an aggregate of 1,600,000 bonus common shares to subscribers. These shares will be subject to a four month hold period commencing from the date of issuance thereof, in accordance with applicable securities laws. Closing of the Offering is scheduled to occur on or about June 11, 2025, and remains subject to customary closing conditions, including receipt of all necessary corporate and regulatory approvals, including TSX Venture Exchange ("TSXV") acceptance. For further information regarding the Offering, please refer to the Company's news release dated June 6, 2025, available on SEDAR+ at About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. Notice regarding Forward Looking Information and Legal Disclaimer This news release contains certain forward-looking information. All statements included herein, other ‎than statements of historical fact, are forward-looking information and such information involves ‎various risks and uncertainties. In particular, this news release contains forward-looking information in ‎relation to: closing of the Offering; TSXV approval of the Notes and issuance of Bonus Shares; the use of proceeds of the Offering; payment of interest on the Notes in cash or common shares, subject to TSXV approval; the Company's payment of finder's fees in connection with the Offering; and investor participation in the Offering. There can be no assurance that ‎such information will prove to be accurate, and actual results and future events could differ materially ‎from those anticipated in such information. This forward-looking information reflects Nanalysis's ‎current beliefs and is based on information currently available to Nanalysis and on assumptions ‎Nanalysis believes are reasonable. These assumptions include, but are not limited to: the current share ‎price of Nanalysis's common shares; TSXV acceptance and market acceptance of ‎the offering; Nanalysis' ‎general and administrative costs remaining constant; and market acceptance of Nanalysis's business ‎model, goals and approach. Forward-looking information is subject to known and unknown ‎risks, uncertainties and other factors which may cause the actual results, performance ‎or achievements of Nanalysis to be materially different from those expressed or implied by such ‎forward-looking information. Statements with forward looking information are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Readers ‎should not place undue reliance on forward-looking information. Nanalysis does not undertake to ‎update any forward-looking information except in accordance with applicable securities laws.‎ This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the ‎securities in the United States. The securities have not been and will not be registered under the United ‎States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and ‎may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons ‎unless registered under the U.S. Securities Act and applicable state securities laws, unless an ‎exemption from such registration is available.‎ Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. SOURCE Nanalysis Scientific Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Enovis to Participate in Upcoming Investor Conferences
Enovis to Participate in Upcoming Investor Conferences

Yahoo

time11 hours ago

  • Yahoo

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Goldman Sachs 46th Annual Global Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, June 10th at 2:00 p.m. Eastern Time. Citizens Medical Devices and Healthcare Services Forum: Ben Berry, Chief Financial Officer, will participate in investor meetings on Tuesday, June 17th. A link to the live audio webcasts, if available, as well as a replay of these events, will be available on the Company's website under the Investors tab at Events and Presentations. ABOUT ENOVIS Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company's extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company's shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit Contact: Kyle RoseVice President, Investor RelationsEnovis Corporationinvestorrelations@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store